国际麻醉学与复苏杂志   2025, Issue (7): 0-0
    
舒更葡糖钠用于深肌松腹腔镜胃癌根治术患者的作用分析
张晓婷, 王宏志, 张劲, 赵丽, 朱毅, 刘毅, 田首元1()
1.山西省肿瘤医院
Analysis of sugammadex on deep neuromuscular blockade in patients undergo-ing laparoscopic radical gastrectomy
 全文:
摘要:

目的 评价舒更葡糖钠对深肌松腹腔镜胃癌根治术患者术后恢复及凝血功能的影响。 方法 本研究为前瞻性研究。选取2023年5月至2024年5月在山西省肿瘤医院拟行腹腔镜胃癌根治术患者226例,年龄18~65岁,体重指数(BMI)18.5~27.9kg/m2,美国麻醉医师协会(ASA)分级Ⅰ~Ⅱ级。采用随机数字表法将入组患者分为新斯的明联合阿托品组(N组,n=113)和舒更葡糖钠组(S组,n=113)。两组患者均在脑电双频指数(BIS)及拇内收肌四个成串刺激肌松监测(TOF)下进行静脉输注丙泊酚,间断静脉推注舒芬太尼及罗库溴胺进行全麻诱导及维持,术后连接静脉镇痛泵自控镇痛。手术结束待TOF计数≥2时,N组患者静脉注射新斯的明0.05mg/kg联合阿托品0.02mg/kg,S组患者静脉注射舒更葡糖钠2mg/kg。记录两组患者气管导管拔除时间、TOF比值(TOFr)≥0.9的时间以及麻醉后恢复室(PACU)停留时间。记录患者入室后(T0)、麻醉诱导前(T1)、给予肌松拮抗剂前(T2)、给予肌松拮抗剂后1min(T3)、给予肌松拮抗剂后5min(T4)和气管导管拔除后30min(T5)的平均动脉压(MAP)及心率(HR)。监测患者入室后(T0)、气管导管拔除后30min(T5)及术后24H(T6)的凝血功能。记录患者PACU低氧血症发生情况、术后7天肺部并发症情况。结果 与N组比较,S组患者拔管时间缩短,肌松恢复至TOFr≥0.9的时间缩短,PACU停留时间缩短。给予肌松拮抗剂后1min(T3)、5min(T4)的MAP与HR,N组患者高于S组。两组患者凝血功能无显著差异。S组患者在PACU期间低氧血症发生率低于N组。两组患者术后7天肺部并发症发生情况无显著差异。结论 腹腔镜胃癌根治术患者术毕使用舒更葡糖钠可更快逆转肌松作用,对患者术后凝血功能及术后肺部并发症发生率无影响。

关键词: 舒更葡糖钠;深肌松;胃癌根治术;肺部并发症;凝血功能
Abstract:

[Abstract] Objective To investigate the effects of Sugammadex on deep neuromuscular blockade recovery and coagulation function in patients undergoing laparoscopic radical gastrectomy. Methods This study was a prospective study.Two hundred and twenty-six patients, aged 18-65 years, with BMI 18.5~27.9 kg/m2,American Society Anesthesiologists grade Ⅰ or Ⅱ,undergoing elective laparoscopic radical gastrectomy in Shanxi Province Cancer Hospital from May 2023 to May 2024, were randomly divided into neostigmine combined with atropine group (group N,n=113) and sugammadex group (group S,n=113) by a random number table method.Patients in both groups received intravenous infusion of propofol , intermittent intravenous infusion of sufentanil and rocuronium for general anesthesia induc-tion and maintenance, and controlled analgesia was connected with intravenous an-algesia pump after operation.During the operation,the bispectral index(BIS) was used to monitor the depth of anesthesia,and the neuromuscular block was assessed with a train-of-four(TOF) stimulus.At end of the surgery, when TOF count ≥2, pa-tients in group N received intravenous neostigmine 0.05mg/kg combined with atro-pine 0.02mg/kg, and patients in group S received intravenous sugammadex 2mg/kg.The time from the administration of neuromuscular blockade antagonists to extubation,and the time from the administration of neuromuscular blockade antagonists to recovery of TOF ratio≥0.9, and the time of post-anesthesia-care-unit (PACU) stay were recorded in both groups.At these time points: after admission (T0), before anesthesia induction (T1), before administration of muscle relaxant antagonists (T2), 1min after administration of muscle relaxant antagonists (T3), 5min after admin-istration of muscle relaxant antagonists (T4), and 30min after extubation (T5), the mean arterial pressure (MAP) and heart rate (HR) were recorded.The coagulation function of patients was monitored after entry (T0), 30min after extubation (T5) and 24H after operation (T6).The occurrence of PACU hypoxemia and pulmonary complications 7 days after operation were recorded. Results Compared with group N, the time to extubation and the time to restore TOFr≥0.9 were shortened significantly in group S.The MAP and HR of patients in group N were higher than those in group S at T3、T4。There was no significant difference in coagulation function between the two groups. The length of stay in PACU was shorter in group S There was no significant difference in pulmonary complications 7 days after operation Conclusion Sugammadex can reverse the residual neuromuscular blockade within shorter time in patients undergoing laparoscopic radical gastrectomy, and have no effect on coagulation function and postoperative pulmonary complications.

Key words: Sugammadex;Deep muscle relaxation;Laparoscopic radical gastrectomy;Pulmonary complications;Coagulation function